Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 267041
                    [Title] => Current status of HCV therapy
                    [Summary] => Major advances have been made in the treatment of chronic hepatitis C during the last 10 years, but major challenges remain, since treatment with pegylated interferons and ribavirin is effective in only around 55 percent of patients. Newer therapies are needed for the increasing numbers of patients who do not respond to relapse after current treatments with pegylated in interferons and ribavirin.


                    [DatePublished] => 2004-12-05 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

RIBAVIRIN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 267041
                    [Title] => Current status of HCV therapy
                    [Summary] => Major advances have been made in the treatment of chronic hepatitis C during the last 10 years, but major challenges remain, since treatment with pegylated interferons and ribavirin is effective in only around 55 percent of patients. Newer therapies are needed for the increasing numbers of patients who do not respond to relapse after current treatments with pegylated in interferons and ribavirin.


                    [DatePublished] => 2004-12-05 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Current status of HCV therapy

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 5, 2004 - 12:00am

Major advances have been made in the treatment of chronic hepatitis C during the last 10 years, but major challenges remain, since treatment with pegylated interferons and ribavirin is effective in only around 55...

Opinion